Menu
/REGISTER
Montecito
Giving Guide
PacPremier
Loading...
You are here:  Home  >  'denosumab'
Latest

Amgen pays $290M to exit osteoporosis drug deal

By   /  Thursday, April 3rd, 2014  /  Banking & Finance, Banking Industry, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen pays $290M to exit osteoporosis drug deal

Amgen will pay $290 million to end its collaboration with British drugmaker GlaxoSmithKline to commercialize the osteoporosis drug denosumab in certain markets outside the U.S.

Read More →
Latest

Amgen gets sought-after FDA approval

By   /  Thursday, November 18th, 2010  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen gets sought-after FDA approval

The Food and Drug Administration has approved the use of Amgen’s bone drug denosumab in patients with certain types of cancer, Amgen announced Nov. 18.

Read More →